The appearance of troglitazone, a potent insulin-sensitizing agent, marked a important chapter in the control of type 2 diabetes. However, its removal from the market due to substantial hepatotoxicity spurred https://phoenixqmjs285279.activoblog.com/51165287/troglitazone-and-related-tzds-a-relative-overview